Grimm Joshua C, Magruder J Trent, Kemp Clinton D, Shah Ashish S
Division of Cardiac Surgery, The Johns Hopkins Hospital , Baltimore, MD , USA.
Front Surg. 2015 Aug 19;2:42. doi: 10.3389/fsurg.2015.00042. eCollection 2015.
Left ventricular assist devices have become standard therapy for patients with end-stage heart failure. They represent potential long-term solutions for a growing public health problem. However, initial enthusiasm for this technology has been tempered by challenges posed by long-term support. This review examines these challenges and out current understanding of their etiologies.
左心室辅助装置已成为终末期心力衰竭患者的标准治疗方法。它们为日益严重的公共卫生问题提供了潜在的长期解决方案。然而,对这项技术最初的热情因长期支持带来的挑战而有所降温。本综述探讨了这些挑战以及我们目前对其病因的理解。